sHLA-G ELISA

Summary

HLA-G differs from the other MHC class I genes by its low polymorphism and alternative splicing that generates seven HLA-G proteins, whose tissue-distribution is restricted to normal fetal and adult tissues that display a tolerogeneic function toward both innate and acquired immune cells. Soluble HLA-G is an immunosuppressive molecule inducing apoptosis of activated CD8(+) T cells and down-modulating CD4(+) T cell proliferation. Recently, using specific ELISA to analyse the presence of sHLA-G molecules in culture supernatants of early embryos obtained by in vitro fertilization (IVF) before transfer, several reports demonstrated that positive embryo implantations occurred with embryo secreting sHLA-G molecules. These breakthrough results indicate that sHLA-G ELISA can be a useful biochemical assay in addition to embryo morphology in embryo selection for transfer in IVF treatment if there are other embryos with the same morphology. Furthermore, monitoring of sHLA-G in amniotic fluid and plasma of pregnant women may have an important prognostic value to recognize pathological situations. Other interesting observations suggest that HLA-G molecules seem to be directly involved in transplant acceptation, and their analysis should be taken into consideration when monitoring transplant-patients status. In addition, soluble HLA-G plasma levels are increased in lyphoproliferative disorders or in patients suffering from malignant melanoma, glioma, breast and ovarian cancer.

Features

• The total assay time is less than four hours.
• The kit measures shedded HLA-G1 and HLA-G5.
• Quality controls are tissue culture based.
• Components of the kit are ready-to-use (with the exception of Standard Material and Wash Solution).

Research topic

Reproduction

Assay format

Sandwich ELISA, HRP-labelled antibody

Applications

Amniotic fluid, Cell culture medium, Plasma-Citrate, Plasma-EDTA, Plasma-Heparin, Serum

Sample requirements

25 µl/well

Storage/Shipping

2–8°C

Calibration Curve

Calibration range

3.91 – 125 Units/ml

Limit of detection

3 Units/ml

Intra-assay (Within-Run, n=8)

CV = 7.6 %

Inter-assay (Run-to-Run, n=11)

CV = 5.9 %

Cross-Reactivity

References to this product

• Chen CH, Liao HT, Chen HA, Liu CH, Liang TH, Wang CT, Tsai CY, Chou CT. Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-alpha blocker therapy. Rheumatology (Oxford). 2010 Feb;49 (2):264-70
• Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens. 2008 Oct;72 (4):335-41
• Ciprandi G, Colombo BM, Contini P, Cagnati P, Pistorio A, Puppo F, Murdaca G. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Allergy. 2008 Oct;63 (10):1335-8
• Coulam C.B., Roussev R.G. Soluble HLA G concentrations in culture media from in vitro fertilized human embryos are predicitive of implantation potential. American Journal of Reproducti. 2005;:53:279-309
• Coulam CB, Roussev RG. Soluble HLA G Concentrations in Culture Media From In Vitro Fertilized Human Embryos are Predicative of Implantation Potential. Fertility and Sterility . 84(1):S447-S448 (2005)
• Coulam CB, Roussev RG. Soluble HLA G concentrations in culture media from in vitro fertilized human embryos are predicitive of implantation potential. American Journal of Reproductive Immunology . 53:279-309 (2005)
• Coulam CB, Roussev RG, Lerner S, Zlatopolsky Z, Ilkevitch Y, Tur-Kaspa I. How to predict implantation? No correlation between embryonic aneuploidy and soluble human leukocyte antigen G-concentrations. Fertil Steril. 2009 Jun;91 (6):2408-13
• Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Repro Biomed Online . Aug;13(2):272-7 (2006)
• Desai N, Filipovits J, Singh P, Beman M, Goldfarb J. Assessment of soluble HLA-G levels in day 3 human embryo culture media using a new ELISA kit: Is there a relationship to embryo quality, development and implantation potential?. Fertility & Sterility . Vol. 84, Suppl 1 (S281-S282), September 2005
• Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B. Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens. 2008 Aug;72 (2):137-48
• Eidukaite A, Tamosiunas V. Soluble HLA-G in the peritoneal fluid of women with endometriosis. Fertil Steril . May 15 (2007)
• Giannopoulos K, Schmitt M, Kowal M, Wlasiuk P, Bojarska-Junak A, Rolinski J, Dmoszynska A. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL). Leuk Res. 2008 Dec;32 (12):1815-9
• Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkchiev S. HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol. 2009 Jul;62 (1):25-33
• Kronsteiner B, Peterbauer-Scherb A, Grillari-Voglauer R, , Redl H, Gabriel C, van Griensven M, Wolbank S. Human mesenchymal stem cells and renal tubular epithelial cells differentially. Cellular Immunology. 2010;
• Kusanovic JP, Romero R, Jodicke C, Mazaki-Tovi S, Vaisbuch E, Erez O, Mittal P, Gotsch F, Chaiworapongsa T, Edwin SS, Pacora P, Hassan SS. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2009 Dec;22 (12):1151-66
• Laskowska M, Laskowska K,Oleszczuk K. Umbilical Serum sHLA-G Levels in Preeclamptic Pregnancies with and without Intrauterine Fetal Growth Restriction: A Comparison with Normotensive Pregnancies with Isolated IUGR and Healthy Controls. International Scholarly Resear. 20 July 2011;2011:6
• Le Maux A, Noel G, Birebent B, Grosset JM, Vu N, De Guibert S, Bernard M, Semana G, Amiot L. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol. 2008 Apr;152 (1):50-6
• Levitsky J, Miller J, Wang E, Rosen A, Flaa C, Abecassis M, Mathew J, Tambur A. Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents. Hum Immunol. 2009 Mar;70 (3):146-50
• Mach P, Blecharz P, Basta P, Marianowski P, Skret-Magierlo J, Kojs Z, Grabiec M, Wicherek L. Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis. Am J Reprod Immunol. 2010 May;63 (5):387-95
• McCormick J, Whitley GS, Le Bouteiller P, Cartwright JE. Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod. 2009 Jun;24 (6):1339-45
• Raicevic G, Rouas R, Najar M, Stordeur P, Boufker HI, Bron D, Martiat P, Goldman M, Nevessignsky MT, Lagneaux L. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol. 2010 Mar;71 (3):235-44
• Roman A, Rodriguez M, Herraiz MA, Jorda J, Cervera I, Penaloza J, Vidart JA, Martinez-Laso J. Heterogeneous expression of HLA-G1, -G2, -G5, -G6, and -G7 in myeloid and plasmacytoid dendritic cells isolated from umbilical cord blood. Hum Immunol. 2009 Feb;70 (2):104-9
• Roussev R.G., Acacio B., Parrett S., Romineb H., Coulam C.B. Soluble HLA-G as potential candidate to help morphology grading score in embryo selection for IVF/ET. Journal of Reproductive Immuno. 2009;:81, 113–175
• Roussev RG, Suchanek M. Soluble HLA-G in culture medium from individually cultured human embryos is necessary but not essential for successful implantation in IVF/ET. -2005
• Shaikly VR, Morrison IE, Taranissi M, Noble CV, Withey AD, Cherry RJ, Blois SM, Fernandez N. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J Immunol. 2008 Mar 15;180 (6):4330-7
• Solini A, Muscelli E, Stignani M, Melchiorri L, Santini E, Rossi C, Astiarraga BD, Rizzo R, Baricordi OR. Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity. J Clin Endocrinol Metab. 2010 Jul;95 (7):3342-6
• Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol . Apr;57(4):277-86 (2007)
• Tahan F, Patiroglu T. Plasma soluble human leukocyte antigen G levels in asthmatic children. Int Arch Allergy Immunol . 141(3):213-6 (2006)
• Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X. Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril. 2008 Nov;90 (5):1599-604
• Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain. 2005 Nov;128 (Pt 11):2689-704
• Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol . May 1;168(9):4772-80 (2002)
• Zhu CB, Wang CX, Zhang X, Zhang J, Li W. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer. 2011 Feb 1;128 (3):617-22

References to summary

• Fujii T., Ishitani A., Geraghty D.E.: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol. 1994; 153: 5516–5524
• Le Bouteiller P., Mallet V.: HLA-G and pregnancy. Rev Reprod. 1997; 2: 7–13
• Blaschitz A., Lenfant F., Mallet V., Hartmann M., Bensussan A., Geraghty D.E., Le Bouteiller P., Dohr G.: Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur Immunol. 1997; 27: 3380–3388
• Chu W., Fant M.E., Geraghty D.E., Hunt J.S.: Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts. Hum Immunol. 1998; 59: 435–442
• Moreau P., Paul P., Rouas-Freiss N., Kirszenbaum M., Dausset J., Carosella E.D.: Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. Am J Reprod Immunol. 1998; 40: 136–144
• Rebman V., Pfeiffer K., Passler M., Ferrone S., Maier S., Weiss E., Grosse-Wilde H.: Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens. 1999; 53: 14–22
• Hunt J.S., Jadhav L., Chu W., Geraghty D.E., Ober C.: Soluble HLA-G circulates in maternal blood during pregnancy. J Am Obstet Gynecol. 2000; 183: 682–688
• Emmer P.M., Steegers E.A., van Lierop M.J., Steegers-Theunissen R.P., Loke Y.W., Joosten I.: Amniotic fluid soluble human leukocyte antigen G is markedly decreased in offspring with neural tube defects. Early Hum Dev. 2002; 66: 101–105
• Fuzzi B., Rizzo R., Criscuoli L., Noci I., Melchiorri L., Scarselli B., Bencini E., Menicucci A., Baricordi O.R.: HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol. 2002; 32: 311–315
• Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., Dausset J., Carosella E.D., Carpentier A.: Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation. 2002; 105: 1949–1954
• Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., Rouas-Freiss N.: HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol. 2003; 81: 199–252
• LeMaoult J., Le Discorde M., Rouas-Freiss N., Moreau P., Menier C., McCluskey J., Carosella E.D.: Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens. 2003; 62: 273–284
• Le Bouteiller P., Legrand-Abravanel F., Solier C.: Soluble HLA-G1 at the materno-foetal interface—a review. Placenta. 2003; 24 Suppl A:S10–5
• Steinborn A., Rebmann V., Scharf A., Sohn C., Grosse-Wilde H.: Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol. 2003; 23: 307–314
• Le Bouteiller P., Pizzato N., Barakonyi A., Solier C.: HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol. 2003; 59: 219–234
• Creput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., Charpentier B., Carosella E.D., Rouas-Freiss N.: Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol. 2003; 39: 587–594
• Sebti Y., Le Friec G., Pangault C., Gros F., Drenou B., Guilloux V., Bernard M., Lamy T., Fauchet R., Amiot L.: Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol. 2003; 64: 1093–1101
• Rebmann V., Regel J., Stolke D., Grosse-Wilde H.: Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol. 2003; 13: 371–377 sHLA-G ELISA (page 13 of 16) VERSION: 33 120607 15
• Sher G., Keskintepe L., Nouriani M., Roussev R., Batzofin J.: Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of 'embryo competency and IVF outcome. Reprod Biomed Online. 2004; 9: 74–78
• Noci I., Fuzzi B., Rizzo R., Melchiorri L., Criscuoli L., Dabizzi S., Biagiotti R., Pellegrini S., Menicucci A., Baricordi O.R.: Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod. 2005; 20: 138–146
• Noci I., Fuzzi B., Rizzo R., Melchiorri L., Criscuoli L., Dabizzi S., Biagiotti R., Pellegrini S., Menicucci A., Baricordi O.R.: Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum Reprod. 2005; 20: 138–146
• Yie S.M., Balakier H., Motamedi G., Librach C.L.: Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil Steril. 2005; 83: 30–36
• Rebman V., Lemaoult J., Rouas-Friess N., Carosella E.D., Grosse-Wilde H.: Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol. 2005; 66: 853–863
• Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., Rouas-Freiss N.: Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol. 2006; 176: 3266–3276
• Gros F., Sebti Y., de Guibert S., Branger B., Bernard M., Fauchet R., Amiot L.: Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia. 2006; 8: 223–230
• Luque J., Torres M.I., Aumente M.D., Marin J., Garcia-Jurado G., Gonzalez R., Pascual D., Guerra N., Lopez-Rubio F., Alvarez-Lopez M.R., Arizon J.M., Pena J.: Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol. 2006; 67: 257–263

By research topic:

• Reproduction

By molecule:

• HLA-G

Registration form